Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Asian Journal of Endoscopic Surgery|November 4, 2020
The influence of reviewer's occupation on the skill assessment of urethrovesical anastomosis in robot-assisted radical prostatectomyKenichiro Fukuoka, Jun Teishima, Shogo Inoue, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 20, 2024
[CLINICAL OUTCOMES OF CYTOREDUCTIVE PROSTATECTOMY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER]Kenichiro Fukuoka, Tomoki Furutani, Naofumi Nomura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 21, 2023
[POSTOPERATIVE RECURRENCE OF RENAL CELL CARCINOMA AFTER THE LAPAROSCOPIC PARTIAL NEPHRECTOMY]Takafumi Fukushima, Kenta Fujiyama, Kyosuke Iwane, et al.
Anatomical Record (Hoboken, N.J. : 2007)|October 6, 2018
The Embryonic Ascent of the Kidney RevisitedKenichiro Fukuoka, Joerg Wilting, Jose Francisco Rodríguez-Vázquez, et al.
Asian Journal of Endoscopic Surgery|October 29, 2020
Impact of postoperative acute kidney injury on predicting the upstaging of chronic kidney disease after robot-assisted partial nephrectomyJun Teishima, Shogo Inoue, Shunsuke Miyamoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 15, 2026
Real-World Effectiveness and Safety of Pembrolizumab-Lenvatinib Versus Axitinib-Based Regimens in Metastatic Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective StudyKohei Kobatake, Keisuke Goto, Akira Fujita, et al.
International Urology and Nephrology|September 26, 2019
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancerKenichiro Fukuoka, Jun Teishima, Hirotaka Nagamatsu, et al.
World Journal of Urology|August 11, 2025
Risk classification by pathological and biochemical prognostic factors determined by extensive exploration for metastatic hormone sensitive prostate cancerKeisuke Goto, Kohei Kobatake, Kenichiro Fukuoka, et al.
The Prostate|April 22, 2026
Impact of the Nadir Androgen Receptor Signaling Inhibitor-Derived Integrative Response Model in Real-World Patients With Metastatic Castration-Sensitive Prostate CancerKazuma Yukihiro, Yohei Sekino, Keisuke Goto, et al.
Urologic Oncology|August 10, 2025
Modified Glasgow prognostic score predicts outcomes of tyrosine kinase inhibitor monotherapy and immune checkpoint inhibitor combination therapy for metastatic renal cell carcinomaKazuma Yukihiro, Keisuke Goto, Nanami Taketomi, et al.
Pageof 2